{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:06:33Z","timestamp":1790431593377,"version":"4.1.0"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,9]]},"DOI":"10.18632\/oncotarget.9958","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T11:32:07Z","timestamp":1465817527000},"page":"51608-51618","source":"Crossref","is-referenced-by-count":67,"title":["Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice"],"prefix":"10.18632","volume":"7","author":[{"given":"Meng-Chuan","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lin","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Radiation Oncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-An","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tz-Chong","family":"Chou","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Biotechnology, Asia University, Taichung, Taiwan"},{"name":"China Medical University Hospital, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Gascon","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MCO.0b013e3283455e21","article-title":"Cancer cachexia therapy: a key weapon in the fight against cancer","volume":"14","author":"Dalton","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Ottery","year":"2011","journal-title":"Lancet Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score","volume":"40","author":"McMillan","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"5","first-page":"601434","article-title":"Cancer cachexia: mechanisms and clinical implications","author":"Reynolds","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jbspin.2007.04.019","article-title":"Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy","volume":"75","author":"Orazi","year":"2008","journal-title":"Joint Bone Spine"},{"key":"7","first-page":"160","article-title":"Signaling in muscle atrophy and hypertrophy","volume":"23","author":"Sandri","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10408363.2011.586171","article-title":"Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks","volume":"48","author":"Jagoe","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators signaling and metabolic pathways","volume":"16","author":"Guttridge","year":"2012","journal-title":"Cell Metab"},{"key":"10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/07315724.1983.10719905","article-title":"Nutritional assessment in the seriously ill patient","volume":"2","author":"Mullen","year":"1983","journal-title":"J Am Coll Nutr"},{"key":"11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.biocel.2013.04.014","article-title":"Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity","volume":"45","author":"Duarte","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.2001.19.4.1229","article-title":"Gemcitabine and cisplatin for advanced metastatic bladder cancer","volume":"19","author":"Rothmann","year":"2001","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin with methotrexate vinblastine doxorubicin plus cisplatin in patients with bladder cancer","volume":"23","author":"Arning","year":"2005","journal-title":"J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.taap.2010.11.003","article-title":"Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems","volume":"250","author":"Aleo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Steyger","year":"2015","journal-title":"Toxicol Lett"},{"key":"16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/glycob\/cwm014","article-title":"A comparative study of the anti-inflammatory anticoagulant antiangiogenic and antiadhesive activities of nine different fucoidans from brown seaweeds","volume":"17","author":"Grachev","year":"2007","journal-title":"Glycobiology"},{"key":"17","first-page":"768323","article-title":"Anticancer and antitumor potential of fucoidan and fucoxanthin two main metabolites isolated from brown algae","author":"Abdul Kadir","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"18","first-page":"366","article-title":"Brown seaweed fucoidan: biological activity and apoptosis growth signaling mechanism in cancer","volume":"60","author":"Kim","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/glycob\/cwm014","article-title":"A comparative study of the anti-inflammatory anticoagulant antiangiogenic and antiadhesive activities of nine different fucoidans from brown seaweeds","volume":"17","author":"Grachev","year":"2007","journal-title":"Glycobiology"},{"key":"20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia mechanism and treatment","volume":"7","author":"Takabe","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SPC.0b013e32834bddf9","article-title":"Targeting the myostatin signaling pathway to treat muscle wasting diseases","volume":"5","author":"Mitch","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Muscaritoli","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Rossi Fanelli","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview","volume":"2","author":"Springer","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"25","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2015.3845","article-title":"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study","volume":"33","author":"Wu","year":"2015","journal-title":"Oncol Rep"},{"key":"26","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; Regulation by AKT and 14-3-3 proteins","volume":"1813","author":"Ramakrishnan","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3945\/ajcn.113.058388","article-title":"Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia","volume":"98","author":"Schols","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation cachexia and prognosis in patients with cancer","volume":"8","author":"Wigmore","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"29","first-page":"168407","article-title":"Inflammation based regulation of cancer cachexia","author":"Guttridge","year":"2014","journal-title":"Biomed Res Int"},{"key":"30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7150\/ijms.6050","article-title":"Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"10","author":"Zheng","year":"2013","journal-title":"Int J Med Sci"},{"key":"31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I","volume":"154","author":"Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"key":"32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Glass","year":"2004","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2013.03.017","article-title":"Signaling pathways mediating the effects of insulin-like growth factor-I in bovine muscle satellite cells","volume":"372","author":"Jiang","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Han","year":"2010","journal-title":"Cell"},{"key":"35","first-page":"219","article-title":"Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha tumor necrosis factor-alpha and interleukin-6","volume":"12","author":"Lowry","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3390\/md13074436","article-title":"Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1\/VEGF Signaling under Hypoxia","volume":"13","author":"Chou","year":"2015","journal-title":"Mar Drugs"},{"key":"37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lfs.2007.06.001","article-title":"Effect of cisplatin on brush border membrane enzymes and anti-oxidant system of rat intestine","volume":"81","author":"Mahmood","year":"2007","journal-title":"Life Sci"},{"key":"38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ab.2009.12.026","article-title":"Proteasomal activity in skeletal muscle: a matter of assay design muscle type and age","volume":"399","author":"Clemen","year":"2010","journal-title":"Anal Biochem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:55:15Z","timestamp":1589277315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":38,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8,9]]}},"alternative-id":["9958","27323407"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9958","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}